Codexis Inc. (CDXS)
NASDAQ
Closed
Oct 23, 2026
Day's Range
1.2752 wk Range
0.9600Overview - CDXS - Codexis Inc.
Key Statistics
Valuation
Enterprise Value
157.83M
P/E (Trailing)
-2.56
P/E (Forward)
-4.00
PEG Ratio
0.13
Price / Sales (TTM)
1.80
Price / Book
3.54
EV / EBITDA
-8.28
Profitability
Gross Margin
76.45%
Profit Margin
-39.55%
Operating Margin
-75.28%
Return on Assets
-11.73%
Return on Equity
-69.36%
Ownership
Shares Outstanding
91.38M
Float
82.30M
Short % of Shares Outstanding
4.46%
Held by Insiders
7.10%
Held by Institutions
69.40%
Price stats
Beta
2.55
50-Day Avg
1.43
200-Day Avg
1.83
Analyst Consensus
8 analysts
Average price target
$ 6.50Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CDXS - Codexis Inc.
Peers - CDXS - Codexis Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- CDXSNASDAQCodexis Inc140.16MMarket Cap-103.13%52-week change-2.57P/E (Trailing)-39.55%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - CDXS - Codexis Inc.
About
Codexis Inc. is a biotechnology company focused on enzyme engineering and biocatalysis. Codexis develops and commercializes proprietary protein engineering technologies that create tailored enzymes for pharmaceutical manufacturing, RNA synthesis, molecular biology, diagnostics, and other life sciences applications.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
